CMN Weekly (13 December 2024) - Your Weekly CRISPR...
CMN Weekly
Dec. 13, 2024
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Chroma Medicine
Main focus: Epigenetic engineering
Company stage: Pre-clinical
Diseases: Undisclosed
(Epi) Genome-editing tool: Undisclosed
Funding stage: Private
Location: Cambridge, MA, USA
Website: https://chromamedicine.com/
Chroma Medicine is a start-up company focused on engineering the epigenome. The company develops epigenetic editors that are able to either silence or activate genes by targeted methylation and demethylation of DNA. Recently, the company raised $125M in a Series A funding round.
